Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 12.75 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Astellas and Medivation, Inc., a Pfizer company, Eisai, Inc., Exelixis, Inc., Genomic Health, Inc., Merck & Co., Inc., Prometheus Laboratories, Inc., Sanofi Genzyme, and Seattle Genetics, Inc.

New York GU™: 12th Annual Interdisciplinary Prostate Cancer Congress® and other Genitourinary Malignancies

New York GU™: 12th Annual Interdisciplinary Prostate Cancer Congress® and other Genitourinary Malignancies


March 15-16, 2019
The Westin New York at Times Square
270 W 43rd St
New York, NY 10036
(212) 201-2700


12th Interdisciplinary Prostate Cancer Congress and Other GU Malignancies™ Overview

The congress will focus on key clinical topics in the management of genitourinary (GU) malignancies, including optimal use of chemotherapeutic and local therapies, androgen-deprivation therapies, targeted therapies, radiopharmaceuticals, and immunotherapies. Coverage will include discussions of prognostic/predictive marker application and proactive mitigation of predictable treatment-related adverse effects. Promising new and emerging data in the field will be explored, for example, combining and sequencing treatments across the disease continuum. Key questions concerning the application of landmark clinical trial data (eg, PSA screening, decision making for castrate-sensitive prostate cancer) will be answered during this program.

Now in its 12th year, the 2019 New York GU™ (NYGU™) meeting is not to be missed! The meeting will continue its legacy and tradition of providing clinicians with the valuable knowledge and confidence to maintain state-of-the-art care and optimize outcomes for patients with genitourinary malignancies.
 

NYGU™ Target Audience

This educational activity is directed toward medical, surgical, and radiation oncologists involved in the treatment of patients with genitourinary (GU) malignancies. Urologists, fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, nuclear medicine physicians, and other healthcare professionals interested in the treatment of GU malignancies may also participate.

Learning Objectives

After this activity, participants should be better prepared to:

  • Outline the use of patient- and disease-specific characteristics to inform clinical decision-making in the management of patients with GU malignancies
  • Discuss current strategies and practice-changing evidence for the management of patients with GU malignancies across multiple lines of care
  • Explain how to proactively mitigate expected treatment-related toxicities associated with immunotherapeutic and targeted approaches to treat GU cancers
  • Apply emerging clinical trial data for the management of GU malignancies in the context of changing treatment paradigms in the field

Acknowledgment of Commercial Support

This activity is supported by educational grants from Astellas and Medivation, Inc., a Pfizer company, Eisai, Inc., Exelixis, Inc., Genomic Health, Inc., Merck & Co., Inc., Prometheus Laboratories, Inc., Sanofi Genzyme, and Seattle Genetics, Inc.

Co-Chairs

Daniel P. Petrylak, MD
Professor of Medicine (Medical Oncology) and Urology
Director, Prostate and GU Medical Oncology
Director, Prostate Cancer Translational Research Group
Yale Cancer Center
New Haven, CT

Leonard G. Gomella, MD, FACS
The Bernard W. Godwin Professor of Prostate Cancer
Chairman, Department of Urology
Associate Director, Jefferson Kimmel Cancer Center
Clinical Director Jefferson Kimmel Cancer Center Network
Thomas Jefferson University
Philadelphia, PA




Register

You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information


Registration Information


Professional Information


Specialties*

Submit
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
 123456
78910111213
14151617181920
21222324252627
28293031
Filter By